Aspire Biopharma Holdin-CW27ASBPWPreferred / convertible
13F holders, Q3 2024 (September 30)30holders −3
4new positions
6sold out
1famous investor
$0.07avg. 13F price*
At the end of Q3 2024, 30 institutions reported holding Aspire Biopharma Holdin-CW27 (ASBPW) in their 13F filings, down 3 from Q2 2024. 4 opened new positions and 6 sold out. The largest holders were Athos Capital Ltd ($261K), Saba Capital Management, L.P. ($42K) and Linden Advisors LP ($34K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Aspire Biopharma Holdin-CW27
- Filed as
- POWERUP ACQUISITION CORP (Q3 2024)
- CUSIP
- G7207P129
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $11K |
| Exits | 6 | $20K |
All 13F filers, Q2 2024 → Q3 2024: 353,450 shares bought and 936,947 shares sold, net −583,497 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 30 holders
| Athos Capital Ltd | — | No change | 21,383 | $261K |
| Saba Capital Management, L.P. | — | No change | 983,603 | $42K |
| Linden Advisors LP | — | No change | 899,999 | $34K |
| AQR Arbitrage LLC | — | No change | 647,633 | $27K |
| Periscope Capital Inc. | — | Reduce -32.0% | 556,300 | $24K |
| Sculptor Capital LP | — | No change | 500,000 | $19K |
| Verition Fund Management LLC | — | No change | 432,757 | $18K |
| Wolverine Asset Management LLC | — | No change | 401,544 | $17K |
| Barclays PLC | — | No change | 350,000 | $15K |
| Taconic Capital Advisors LP | — | No change | 300,000 | $13K |
| D. E. Shaw & Co. | — | No change | 199,999 | $8K |
| Context Capital Management, LLC | — | New | 175,000 | $7K |
| Nomura Holdings Inc. | — | No change | 150,000 | $6K |
| Clear Street LLC | — | Add +161.4% | 138,566 | $6K |
| Polar Asset Management Partners Inc. | — | No change | 138,536 | $6K |
| Whitebox Advisors LLC | — | No change | 125,000 | $5K |
| Clear Street Derivatives LLC | — | No change | 106,000 | $4K |
| Caas Capital Management LP | — | No change | 75,000 | $3K |
| Blue Owl Capital Holdings LP | — | New | 50,000 | $2K |
| Walleye Capital LLC | — | No change | 46,560 | $2K |
| Cowen and Company, LLC | — | New | 28,700 | $1K |
| Walleye Trading LLC | — | No change | 26,190 | $1K |
| OMERS ADMINISTRATION Corp | — | No change | 25,000 | $1K |
| Adage Capital Partners Gp, L.L.C. | — | No change | 1,050,000 | $1K |
| Picton Mahoney Asset Management | — | No change | 50,000 | $1K |
| Mint Tower Capital Management B.V. | — | No change | 25,000 | $1K |
| Meteora Capital, LLC | — | Reduce -16.0% | 21,000 | $888 |
| PEAK6 Investments LLC | — | No change | 12,500 | $529 |
| HRT Financial LP | — | New | 14,183 | $0 |
| Investors Research Corp | — | No change | 10 | $0 |
"% of holder's portfolio" is ASBPW's weight in each manager's 13F, not the share of Aspire Biopharma Holdin-CW27 the manager owns.